HNB
UTHR icon

Hilltop National Bank’s United Therapeutics UTHR Stock Holding History

Hilltop National Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,187
Closed -$341K – 815
2025
Q2 		$341K Buy
+1,187
New +$355K 0.09% 168

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Hilltop National Bank's UTHR Position: Q3 2025 in Review

Hilltop National Bank sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,187 shares — an estimated $341K sold.

Hilltop National Bank first reported a position in UTHR in Q2 2025 and held it in 1 quarter. The position peaked at $341K in Q2 2025. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Hilltop National Bank reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Hilltop National Bank sold 1,187 United Therapeutics shares in Q3 2025, an estimated $341K.
  • Hilltop National Bank first reported a position in United Therapeutics in Q2 2025 and held it in 1 quarter.
  • Hilltop National Bank's United Therapeutics position peaked at $341K in Q2 2025.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Hilltop National Bank's 13F filing for Q3 2025, filed 8 Oct 2025.